2018
Azithromycin Pharmacodynamics against Persistent Haemophilus influenzae in Chronic Obstructive Pulmonary Disease
Tsuji BT, Fisher J, Boadi-Yeboah R, Holden PN, Sethi S, Pettigrew MM, Murphy TF. Azithromycin Pharmacodynamics against Persistent Haemophilus influenzae in Chronic Obstructive Pulmonary Disease. Antimicrobial Agents And Chemotherapy 2018, 62: 10.1128/aac.01995-17. PMID: 29180527, PMCID: PMC5786777, DOI: 10.1128/aac.01995-17.Peer-Reviewed Original ResearchConceptsChronic obstructive pulmonary disease patientsObstructive pulmonary disease patientsChronic obstructive pulmonary diseaseHollow-fiber infection modelStrains of NTHiPulmonary disease patientsObstructive pulmonary diseasePulmonary diseaseConcentration-dependent activityDisease patientsPharmacodynamic profilePharmacodynamic responseSame patientHaemophilus influenzaeInfection modelPatientsAzithromycinPersistent strainsDaysAirwayNTHiPharmacodynamicsInfluenzaeDiseaseHaemophilus
2011
Behavioural sources of repeat Chlamydia trachomatis infections: importance of different sex partners
Niccolai LM, Livingston KA, Laufer AS, Pettigrew MM. Behavioural sources of repeat Chlamydia trachomatis infections: importance of different sex partners. Sexually Transmitted Infections 2011, 87: 248. PMID: 21212380, PMCID: PMC5438152, DOI: 10.1136/sti.2010.045484.Peer-Reviewed Original ResearchConceptsChlamydia trachomatis infectionRepeat infectionsNew sex partnerTrachomatis infectionSex partnersC. trachomatisRepeat Chlamydia trachomatis infectionsPopulation attributable risk percentageC. trachomatis infectionCumulative incidenceDifferent-sex partnersRisk percentageYounger ageInfectionBehavioral surveyBaselineDifferent genotypesTrachomatisWomenMolecular methodsGenotypesPatientsFollowIncidence